These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

118 related articles for article (PubMed ID: 2078050)

  • 1. Transdermal delivery of 5-fluorouracil through skin of hairless mice and humans in vitro: a comparison of the effect of formulations and a prodrug.
    Sherertz EF; Sloan KB; McTiernan RG
    Arch Dermatol Res; 1990; 282(7):463-8. PubMed ID: 2078050
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Topical delivery of 5-fluorouracil (5-FU) by 3-alkylcarbonyloxymethyl-5-FU prodrugs.
    Roberts WJ; Sloan KB
    J Pharm Sci; 2003 May; 92(5):1028-36. PubMed ID: 12712422
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Topical delivery of 5-fluorouracil (5-FU) by 1,3-bisalkylcarbonyl-5-FU prodrugs.
    Beall HD; Sloan KB
    Int J Pharm; 2002 Jan; 231(1):43-9. PubMed ID: 11719012
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Topical delivery of 5-fluorouracil (5-Fu) by 3-alkylcarbonyl-5-Fu prodrugs.
    Beall HD; Sloan KB
    Int J Pharm; 2001 Apr; 217(1-2):127-37. PubMed ID: 11292549
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Application of hydrotropy to transdermal formulations: hydrotropic solubilization of polyol fatty acid monoesters in water and enhancement effect on skin permeation of 5-FU.
    Takahashi K; Komai M; Kinoshita N; Nakamura E; Hou XL; Takatani-Nakase T; Kawase M
    J Pharm Pharmacol; 2011 Aug; 63(8):1008-14. PubMed ID: 21718283
    [TBL] [Abstract][Full Text] [Related]  

  • 6. 1-Alkylcarbonyloxymethyl prodrugs of 5-fluorouracil (5-FU): synthesis, physicochemical properties, and topical delivery of 5-FU.
    Taylor HE; Sloan KB
    J Pharm Sci; 1998 Jan; 87(1):15-20. PubMed ID: 9452962
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Hairless mouse skin is limited as a model for assessing the effects of penetration enhancers in human skin.
    Bond JR; Barry BW
    J Invest Dermatol; 1988 Jun; 90(6):810-3. PubMed ID: 3373011
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Microemulsion-based gel of fluorouracil for transdermal delivery].
    Xiao YY; Liu F; Chen ZP; Ping QN
    Yao Xue Xue Bao; 2010 Nov; 45(11):1440-6. PubMed ID: 21361046
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Microemulsions as topical delivery vehicles for the anti-melanoma prodrug, temozolomide hexyl ester (TMZA-HE).
    Suppasansatorn P; Nimmannit U; Conway BR; Du L; Wang Y
    J Pharm Pharmacol; 2007 Jun; 59(6):787-94. PubMed ID: 17637171
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Effect of fatty acids on the transdermal delivery of donepezil: in vitro and in vivo evaluation.
    Choi J; Choi MK; Chong S; Chung SJ; Shim CK; Kim DD
    Int J Pharm; 2012 Jan; 422(1-2):83-90. PubMed ID: 22037444
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Water in oil microemulsions containing NaCl for transdermal delivery of fluorouracil].
    Xiao YY; Liu F; Chen ZP; Ping QN
    Yao Xue Xue Bao; 2011 Jun; 46(6):720-6. PubMed ID: 21882535
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Effects of ionization and penetration enhancers on the transdermal delivery of 5-fluorouracil through excised human stratum corneum.
    Singh BN; Singh RB; Singh J
    Int J Pharm; 2005 Jul; 298(1):98-107. PubMed ID: 15913928
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Transdermal delivery of nicardipine: an approach to in vitro permeation enhancement.
    Aboofazeli R; Zia H; Needham TE
    Drug Deliv; 2002; 9(4):239-47. PubMed ID: 12511202
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The effect of 5-fluorouracil on inhibition of epidermal DNA synthesis in vivo: a comparison of the effect of formulations and a prodrug of 5-FU.
    Sloan KB; Sherertz EF; McTiernan RG
    Arch Dermatol Res; 1990; 282(7):484-6. PubMed ID: 2078053
    [No Abstract]   [Full Text] [Related]  

  • 15. Topical delivery of a model phenolic drug: alkyloxycarbonyl prodrugs of acetaminophen.
    Wasdo SC; Sloan KB
    Pharm Res; 2004 Jun; 21(6):940-6. PubMed ID: 15212157
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Formulation and in vitro/in vivo evaluation of levodopa transdermal delivery systems.
    Lee KE; Choi YJ; Oh BR; Chun IK; Gwak HS
    Int J Pharm; 2013 Nov; 456(2):432-6. PubMed ID: 24008082
    [TBL] [Abstract][Full Text] [Related]  

  • 17. AOT water-in-oil microemulsions as a penetration enhancer in transdermal drug delivery of 5-fluorouracil.
    Gupta RR; Jain SK; Varshney M
    Colloids Surf B Biointerfaces; 2005 Mar; 41(1):25-32. PubMed ID: 15698753
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The effect of laser treatment on skin to enhance and control transdermal delivery of 5-fluorouracil.
    Lee WR; Shen SC; Wang KH; Hu CH; Fang JY
    J Pharm Sci; 2002 Jul; 91(7):1613-26. PubMed ID: 12115823
    [TBL] [Abstract][Full Text] [Related]  

  • 19. An attempt to clarify the influence of glycerol, propylene glycol, isopropyl myristate and a combination of propylene glycol and isopropyl myristate on human stratum corneum.
    Brinkmann I; Müller-Goymann CC
    Pharmazie; 2005 Mar; 60(3):215-20. PubMed ID: 15801677
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Ethogel topical formulation for increasing the local bioavailability of 5-fluorouracil: a mechanistic study.
    Puri R; Jain S
    Anticancer Drugs; 2012 Oct; 23(9):923-34. PubMed ID: 22926258
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.